Jeff Auxier (Trades, Portfolio), the seasoned founder and CEO of Auxier Asset Management and manager of the Auxier Focus F ...

United Nations peacekeepers are warning that the Israeli military has committed “severe violations” of a cease-fire deal with ...

Moderna (MRNA) is up more than +3% after reporting Q3 Covid-19 vaccine revenue of $1.8 billion, which is stronger than the consensus of $1.2 billion. Lyft (LYFT) is up more than +29% after reporting ...

Even though the company surprised analysts by reporting net income of $13 million (up from a $3.63 billion net loss in Q3 ...

Stay up-to-date with the latest stock market upgrades and downgrades from top analysts, including Berkshire Hathaway, Charter ...

Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...

Although the revenue and EPS for Moderna (MRNA) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall ...

Moderna ( (MRNA) ) has released its Q3 earnings. Here is a breakdown of the information Moderna presented to its investors. Moderna, Inc. is a ...

Moderna (MRNA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Tyler Van Buren ...

Major indices delivered a mixed performance on Thursday as market participants digested former president Donald Trump's ...

Moderna (NASDAQ: MRNA) Q3 2024 Earnings Call Nov 07, 2024, 8:00 a.m. ET Good day, and thank you for standing by. Welcome to ...